Feng-Mei Zhou

机构：First Affiliated Hospital of Xinxiang Medical University, Henan Cancer Hospital, Third Affiliated Hospital of Zhengzhou University

发表论文 38 篇 · 总被引 501 次 · h-index 13

代表论文

• Elevated NOX4 promotes tumorigenesis and acquired EGFR-TKIs resistance via enhancing IL-8/PD-L1 signaling in NSCLC (2023 · Drug Resistance Updates · 被引 67)
• Apigenin Inhibits IL-6 Transcription and Suppresses Esophageal Carcinogenesis (2019 · Frontiers in Pharmacology · 被引 45)
• Discovery of a New CDK4/6 and PI3K/AKT Multiple Kinase Inhibitor Aminoquinol for the Treatment of Hepatocellular Carcinoma (2021 · Frontiers in Pharmacology · 被引 38)
• Multimodality MRI Radiomics Based on Machine Learning for Identifying True Tumor Recurrence and Treatment-Related Effects in Patients with Postoperative Glioma (2023 · Neurology and Therapy · 被引 22)
• Complementary roles of EP2 and EP4 receptors in malignant glioma (2023 · British Journal of Pharmacology · 被引 20)
• Regulation of MicroRNA-497-Targeting AKT2 Influences Tumor Growth and Chemoresistance to Cisplatin in Lung Cancer (2020 · Frontiers in Cell and Developmental Biology · 被引 20)